Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Frontiers in Oncology|March 16, 2026
MRD in multiple myeloma: the clinical perspectiveTommaso Caravita di Toritto, Angela RagoHaematologica|September 4, 2025
HBV infection in the era of T-cell engagers in multiple myeloma: unresolved challenges and unmet needs. Comment on: Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with hematological malignanciesAngela Rago, Lorenzo Ridola, Tommaso Caravita Di TorittoSupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 22, 2018
Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic reviewFrancesco Sparano, Michele Cavo, Pasquale Niscola, et al.Ejhaem|February 23, 2023
Immunotactoid glomerulopathy and chronic lymphocytic leukemia: The need for a multidisciplinary approachAngela Rago, Laura Pettorini, Alessandro Andriani, et al.Nature Clinical Practice. Oncology|July 11, 2006
Bortezomib: efficacy comparisons in solid tumors and hematologic malignanciesTommaso Caravita, Paolo de Fabritiis, Antonio Palumbo, et al.BMJ Case Reports|June 21, 2011
Management of immune thrombocytopoenia in a patient with newly-diagnosed smouldering myeloma and colorectal cancerAgostina Siniscalchi, Roberto Stasi, Stefano Fratoni, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|March 17, 2020
Onset and Progression of Precancerous Lesions on Gastric Mucosa of Patients Treated for Gastric LymphomaAngelo Zullo, Angela Rago, Stefano Felici, et al.Tumori|February 2, 2021
Pulmonary arterial hypertension in a patient with multiple myeloma during carfilzomib treatment: in search of better managementAngela Rago, Agostina Siniscalchi, Attilio Tordi, et al.Haematologica|June 14, 2005
Correlation between fatigue and hemoglobin level in multiple myeloma patients: results of a cross-sectional studyAntonio Palumbo, Maria Teresa Petrucci, Vito Michele Lauta, et al.Cancer|August 24, 2005
Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myelomaAntonio Palumbo, Alessandra Bertola, Pellegrino Musto, et al.Pageof 6